Balyasny Asset Management LLC Biomarin Pharmaceutical Inc Transaction History

Balyasny Asset Management LLC

  • $63.6 Billion
  • Q4 2024

A detailed history of Balyasny Asset Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Balyasny Asset Management LLC holds 337,103 shares of BMRN stock, worth $21.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
337,103
Previous 50,000 574.21%
Holding current value
$21.9 Million
Previous $3.51 Million 530.54%
% of portfolio
0.03%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$61.93 - $70.49 $35.5 Million - $40.4 Million
-573,513 Reduced 62.98%
337,103 $22.2 Million
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $7.79 Million - $10.6 Million
-112,876 Reduced 11.03%
910,616 $64 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $58.5 Million - $72.5 Million
786,547 Added 331.95%
1,023,492 $84.3 Million
Q1 2024

May 13, 2024
SELL
$83.81 - $99.0 $15.7 Million - $18.6 Million
-187,624 Reduced 44.19%
236,945 $20.7 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $37 Million - $47.9 Million
-485,827 Reduced 53.36%
424,569 $40.9 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $67.5 Million - $75 Million
793,863 Added 681.23%
910,396 $80.6 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $16.4 Million - $19 Million
-189,591 Reduced 61.93%
116,533 $10.1 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $8.64 Million - $11.6 Million
98,520 Added 47.46%
306,124 $29.8 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $46.8 Million - $62.8 Million
-578,184 Reduced 73.58%
207,604 $21.5 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $18.2 Million - $21.4 Million
221,090 Added 39.15%
785,788 $66.6 Million
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $39 Million - $47.4 Million
545,848 Added 2895.75%
564,698 $46.8 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $1.4 Million - $1.75 Million
18,850 New
18,850 $1.45 Million
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $1.48 Million - $1.67 Million
-19,657 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$74.73 - $90.69 $10.7 Million - $13 Million
-143,752 Reduced 87.97%
19,657 $1.48 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $9.21 Million - $11.4 Million
126,828 Added 346.7%
163,409 $14.3 Million
Q3 2020

Nov 16, 2020
SELL
$71.87 - $131.03 $5.05 Million - $9.2 Million
-70,245 Reduced 65.76%
36,581 $2.78 Million
Q2 2020

Aug 14, 2020
SELL
$79.55 - $124.22 $20.6 Million - $32.2 Million
-259,466 Reduced 70.84%
106,826 $13.2 Million
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $18.4 Million - $25 Million
-258,125 Reduced 41.34%
366,292 $31 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $30.7 Million - $41.2 Million
477,401 Added 324.73%
624,417 $52.8 Million
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $17.6 Million - $22.2 Million
-260,750 Reduced 63.95%
147,016 $9.91 Million
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $31.6 Million - $36.9 Million
393,462 Added 2750.71%
407,766 $34.9 Million
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $18.4 Million - $21.5 Million
-218,287 Reduced 93.85%
14,304 $1.27 Million
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $23.3 Million - $30.8 Million
-290,220 Reduced 55.51%
232,591 $19.8 Million
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $9.96 Million - $11.2 Million
106,041 Added 25.44%
522,811 $50.7 Million
Q2 2018

Aug 14, 2018
SELL
$76.01 - $99.03 $47.2 Million - $61.6 Million
-621,529 Reduced 59.86%
416,770 $39.3 Million
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $55.4 Million - $66.1 Million
-713,092 Reduced 40.72%
1,038,299 $84.2 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $55.7 Million - $65.6 Million
689,779 Added 64.97%
1,751,391 $156 Million
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $85.6 Million - $101 Million
1,061,612
1,061,612 $98.8 Million

Others Institutions Holding BMRN

# of Institutions
626
Shares Held
183M
Call Options Held
2M
Put Options Held
1.67M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email